Team Consulting has been the partner of choice for global medical clients for over 40 years. Building on our reputation of delivering world-leading medical device programmes, Ben Cox will be transitioning into the role of Commercial Director from the 1st of June to continue driving new healthcare innovations.
Ben will be succeeding Andrew Pocock, who for the past 14 years has played a key role in shaping how we work with clients and build long‑term partnerships. During his time as Commercial Director, Andy has established Team’s trusted relationships with our global client base, helping them to navigate complex technical and commercial challenges and progress ambitious medical device programmes with confidence.
In recent years Team has expanded its expertise into new areas. A trusted partner to 9 out of the top 10 pharmacos, we continue to work with clients at the cutting edge of medical technology and design, including cell and gene therapies, targeted drug delivery, digital health, neurotech, nuclear medicine and more.
As an employee-owned business, we focus on delivering the best value to our clients. Just a few of our client success stories include the UK’s most valued MedTech “unicorn”, the award-winning OrganOx, acquired by Terumo for $1.5 billion, as well as TympaHealth, whose world-first ear and hearing system recently won a DBA Design Effectiveness Award. More recently, we’ve celebrated two PDA Partnership in Innovation awards alongside AstraZeneca, marking 14 years of award-winning innovations with our clients.
Ben’s appointment reinforces what matters most to us when working with our clients: consistent, high quality support from a team that deeply understands their challenges and the industry. Ben has been part of Team since 2011 and brings a combination of scientific rigour, user-centred design expertise, and commercial leadership. His focus has always been on helping clients turn their product visions into solutions that are robust, usable and market-leading.
Beginning his career as a Clinical Scientist and Bioengineer within the NHS, Ben went on to lead human factors and user experience programmes for global pharmaceutical and MedTech clients across drug delivery, diagnostics, and surgical sectors. In his current role as Head of Digital Health, he successfully leads one of Team’s emerging commercial sectors, overseeing business strategy and client engagement across international markets. Combined with his academic background in biomedical engineering, this gives him the technical depth and practical insight to work closely with our clients, understand their unique challenges and commercial needs, and help find the best ways to maximise value in their development.
As we thank Andrew for his years of commitment to client success, Ben’s transition allows us to ensure the continued delivery of exceptional work helping development teams to move faster, manage risk and bring better products to patients and healthcare professionals.
Ben would welcome the opportunity to discuss how Team can help clients reach their goals. Get in touch to see how we can help you.
Looking for industry insights? Click below to get our opinions and thoughts into the world of medical devices and healthcare.
